GB/T 20523-2006
Active
T/CASME 276-2022
Active
Group standards
T/CASME 276-2022 Biopharmaceutical raw material R&D enterprise safety management specification
T/CASME 276-2022 Biopharmaceutical raw material R&D enterprise safety management specification
Price:
$ 20.00
Basic Information
Standard Code:
T/CASME 276-2022
Standard Type:
Group standards
Standard Status:
Active
is_force_gb:
no
CCS Name:
Medicine, health, and labor protection
ICS Name:
Other standards related to the organization and management of companies (enterprises)
Publish Date:
2022-12-29
Implement Date:
2022-12-31
Scope
Scope: This document applies to the safety management of internal R&D activities in biopharmaceutical raw material R&D enterprises; Main technical content: This document stipulates the basic requirements, safety operating procedures, safety education and training, safety risk management, hidden danger inspection and treatment, R&D process management, trial production management, facility and equipment management, accident management, emergency management, and evaluation and improvement of biopharmaceutical raw material R&D enterprises.
Development Information
Related Standards
SB/T 10444-2007
Active
SB/T 10444-2007 Credit management technical specification for commercial enterprises
GB/T 22116-2008
Active
GB/T 22116-2008 Expression of enterprise's credit grade
GB/T 22125-2008
Active
GB/T 22125-2008 Operation and management regulations for enterprises of marketing automobile parts
GB/T 22152-2008
Active
GB/T 22152-2008 Guideline on international freight forwarding business statistic
GB/Z 23692-2009
Active